MICHAELA SMITH: Open Payments
NPI 1013760131 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Amgen Inc. | 2 | $65 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
Products named: AIRSUPRA, EVENITY, CAMZYOS, Wegovy, MOUNJARO, NEXLETOL.
Industry payments across MA — which companies pay providers there.
